Madeline Kaklis
Nurse Practitioner · Washington, DCNPI 1821804659
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.2% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 9.3% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $28.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$192
- Merck$186
- AstraZeneca$184
- Daiichi Sankyo Inc.$174
- Sanofi$124
- Lilly USA, LLC$121
- plus $1K from 25 others
What the payments were for
- Food & beverage$1,85090%
- Education$20010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $192 |
| Merck | 7 | $186 |
| AstraZeneca(2 entities) | 8 | $184 |
| Daiichi Sankyo Inc. | 8 | $174 |
| Sanofi | 1 | $124 |
| Lilly USA, LLC | 3 | $121 |
| Incyte Corporation | 4 | $99 |
| Novartis | 4 | $95 |
| Gilead | 1 | $95 |
| EMD Serono, Inc. | 3 | $64 |
| Pharmacosmos Therapeutics Inc. | 2 | $63 |
| Exelixis Inc. | 2 | $62 |
| Beone Medicines USA, Inc. | 2 | $55 |
| Tersera Therapeutics LLC | 2 | $55 |
| Boston Scientific | 1 | $50 |
| Azurity Pharmaceuticals, Inc. | 2 | $41 |
| Novocure Inc. | 1 | $35 |
| Karyopharm Therapeutics Inc. | 1 | $33 |
| Agios Pharmaceuticals, Inc. | 1 | $30 |
| Genmab U.S., Inc. | 1 | $30 |
| Bayer | 1 | $28 |
| Eisai Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $26 |
| Bristol Myers Squibb | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Array Biopharma Inc | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Coherus Oncology, Inc. | 1 | $23 |
| Sobi, Inc | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Puma Biotechnology, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SARCLISA$124
How this compares
$2,050 in reported general payments places this provider in the 90th percentile of 224 nurse practitioner providers in District of Columbia.
See all nurse practitioner providers in District of Columbia →
Other nurse practitioner in Washington
- Rasheda PersingerWashington$88K
- Caitlin YazelWashington$45K
- Aimee LestrangeWashington$37K
- Guinevere QueWashington$27K
- Cynthia BitherWashington$17K
- Safia AbdillahiWashington$11K
- Brigid ReynoldsWashington$6K
- Odette NtamWashington$5K
- Kathryn HilgartnerWashington$5K
- Mary AlderWashington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.